Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Pursuant to the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company in their meeting held today has granted 25,000 stock options to an eligible employee under the Strides ESOP Plan 2016 at Rs. 311/- per option (exercise price). The shares covered by such options are 25,000 equity shares. The vesting period of these options is in a phased manner over a period of 3 years. The options are exercisable within a period of 12 months (exercisable in not more than two tranches) from the date of vesting.
20-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 The Board of Directors of the Company in their meeting held today have allotted 2,200 equity shares of face value of Rs. 10/- each to the eligible employees who have exercised their stock options under Strides ESOP 2016 Plan. These shares shall rank in pari passu with the existing equity shares of the Company in all respects. Consequent to above, the paid-up share capital of the Company has increased from Rs. 89,56,54,640 consisting of 8,95,65,464 equity shares to Rs. 89,56,76,640/- consisting of 8,95,67,664 equity shares of Rs. 10/- each.
20-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Corporate Action-Board to consider Dividend

 Board of Directors at their meeting held today i.e., on May 20, 2020, have recommended final dividend of at Rs. 2/- per equity share of Rs. 10/- each for the financial year ended March 31, 2020. The dividend will be paid within 30 days from the date of shareholder's approval at the ensuing Annual General Meeting of the Company. After taking into account the interim dividend of Rs. 12/- per share paid by the Company in the month of August 2019, total dividend for the financial year stands at Rs. 14/- per equity share. This is for your information and record.
20-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For The Quarter/ Year Ended March 31, 2020

 The Board of Directors at their meeting held today i.e., on May 20, 2020, have approved and adopted the Audited Financial Statements along with the Auditors' Report for the quarter/ year ended March 31, 2020. In this regard, please find enclosed the following: a)Audited Financial Statements (Standalone and Consolidated) along with Auditors' Report for the financial year ended March 31, 2020; b)Press Release tilted 'Strides announces Q4FY20 and FY20 Financial results'. The board meeting commenced at 18:15 hrs and concluded at 19:45 hrs. This is for your information and record.
20-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd
20-05-2020
Bigul

Annual report for Strides Pharma Science Ltd. for FY-2020
20-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 We write to inform that the Company shall host earnings call with analysts and investors on Thursday, May 21, 2020, at 08:30 am IST to discuss the audited financial results of the Company for the quarter and year ended March 31, 2020. The transcript of the conference call will be posted on the Company's website at www.strides.com.
19-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 In compliance with SEBI Circular No. CIR/ CFD/ CMD1/ 27/ 2019 dated February 8, 2019, please find enclosed copy of Annual Secretarial Compliance Report dated May 14, 2020 for the year ended March 31, 2020 issued by M/s. Gopalakrishnaraj H H & Associates, Practicing Company Secretaries. We request you to kindly take the same on record.
19-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith newspaper advertisement published in Business Standard and Lokmath, both dated May 12, 2020 about intimation of Board Meeting scheduled to be held on Wednesday, May 20, 2020 to consider and approve, inter-alia, the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2020 and to consider and recommend dividend on equity shares of the Company, if any This is for your kind information and record purposes.
13-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith newspaper advertisement published in Business Standard and Lokmath, both dated May 12, 2020 about intimation of Board Meeting scheduled to be held on Wednesday, May 20, 2020 to consider and approve, inter-alia, the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2020 and to consider and recommend dividend on equity shares of the Company, if any This is for your kind information and record purposes.
13-05-2020
Next Page
Close

Let's Open Free Demat Account